Subtype
Uterine Corpus Neoplasm
CI-CAN-00007035Explore in graph →
Non-malignant451 active trials4 approved drugs28 evidence items
- NCIt
- C6300
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007035Explore in graph →
Clinical trials
1,714 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06795009 | Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer | recruiting | Phase 1 | 36 | Washington University School of MedicineOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06943521 | A Study of MT-4561 in Patients With Various Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 27 | Tanabe Pharma America, Inc.INDUSTRY | 2 | Dec 11, 2025 | clinicaltrials |
| NCT05077215 |
| Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer |
| not yet recruiting |
| Phase 3 |
| 450 |
| Evergreen Therapeutics, Inc.INDUSTRY |
| 0 |
| Dec 8, 2025 |
| clinicaltrials |
| NCT05106127 | Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem | not yet recruiting | Phase 2 | 28 | Evergreen Therapeutics, Inc.INDUSTRY | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07269535 | A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma | not yet recruiting | — | 500 | Tongji HospitalOTHER | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07267780 | Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. | not yet recruiting | — | 130 | National Cancer Institute, NaplesOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT05201547 | Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line(DOMENICA) | active not recruiting | Phase 3 | 260 | ARCAGY/ GINECO GROUPOTHER | 10 | Dec 4, 2025 | clinicaltrials |
| NCT07070518 | Study of GV20-0251 in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 350 | GV20 TherapeuticsINDUSTRY | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07258186 | Generation of Endometrial Carcinoma Organoids(organoids endo) | recruiting | — | 20 | Regina Elena Cancer InstituteOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT03983954 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | active not recruiting | Phase 1 | 120 | NeoTX Therapeutics Ltd.INDUSTRY | 2 | Nov 28, 2025 | clinicaltrials |
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07230444 | Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization(AI-EMBO) | not yet recruiting | — | 250 | Emanuele BarabinoOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07235787 | Efficacy of Ultrasound Guided Microwave Ablation in the Treatment of Uterine Fibroids.(MWAUF) | not yet recruiting | N/A | 20 | Jihad Hussien Mohamed MahmoudOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06935305 | OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer(SENT-OSNA) | recruiting | N/A | 1,922 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05997017 | Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer | recruiting | Phase 2 | 29 | Aadi Bioscience, Inc.INDUSTRY | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06677112 | MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer | recruiting | N/A | 625 | Rachel MillerOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07084168 | Multimedia Aid for Genetic Testing in Gynecologic Oncology | recruiting | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | recruiting | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | recruiting | Phase 1 / Phase 2 | 200 | Volastra Therapeutics, Inc.INDUSTRY | 1 | Nov 4, 2025 | clinicaltrials |
| NCT06481592 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. | recruiting | Phase 2 | 60 | Iovance Biotherapeutics, Inc.INDUSTRY | 1 | Oct 30, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT04574635 | Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer | active not recruiting | — | 18 | Mayo ClinicOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT04586959 | Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer(MAN-U) | recruiting | N/A | 278 | Anthony Costales, MDOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT04106414 | Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment | active not recruiting | Phase 2 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT04250766 | Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)(BIOPSAR) | active not recruiting | N/A | 19 | Institut BergoniéOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04512144 | Mindfulness in Endometrial and Cervical Cancer(MECCA) | recruiting | N/A | 120 | St. Louis UniversityOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT06861855 | Prognosis of METTL-14 in Endometrial Carcinoma | not yet recruiting | — | 50 | Assiut UniversityOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT02628067 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | active not recruiting | Phase 2 | 1,609 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 22, 2025 | clinicaltrials |
| NCT04763915 | Improving Care After Inherited Cancer Testing(IMPACT) | active not recruiting | N/A | 720 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT07027046 | Application of da Vinci SP for Endometrial Cancer Surgical Staging | recruiting | — | 564 | National Cancer Institute, NaplesOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06663553 | Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus | not yet recruiting | N/A | 210 | West China Second University HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07177534 | Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model | not yet recruiting | — | 7,084 | Tongji HospitalOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT07078682 | An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms | recruiting | N/A | 42 | Zenchi, Inc.INDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07170982 | Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer | not yet recruiting | Phase 2 | 128 | Sun Yat-sen UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06802198 | A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes(STORY) | not yet recruiting | N/A | 500 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT07153952 | RT for Adenocarcinoma/Adenosquamous Carcinoma | active not recruiting | Phase 1 / Phase 2 | 60 | Peking Union Medical College HospitalOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06169449 | Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment | recruiting | N/A | 240 | Peking University People's HospitalOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07148154 | Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations | recruiting | — | 3,000 | MiMARK Diagnostics, S.L.INDUSTRY | 1 | Aug 29, 2025 | clinicaltrials |
| NCT07146659 | Comparison of Operative Hysteroscopy Performed in the Operating Room Versus Outpatient Settings | recruiting | — | 400 | Centre Hospitalier Intercommunal CreteilOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT07137299 | POPQ Associated With Total Laparoscopic Hysterectomy(POP-LAP) | not yet recruiting | — | 2,000 | Medical University of SilesiaOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07115927 | pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer(RODEO) | not yet recruiting | Phase 2 | 40 | University College, LondonOTHER | 0 | Aug 19, 2025 | clinicaltrials |
| NCT07129005 | Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids | enrolling by invitation | — | 520 | Tongji HospitalOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 914 | ExelixisINDUSTRY | 9 | Aug 17, 2025 | clinicaltrials |
| NCT00788671 | Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer | active not recruiting | Phase 2 | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT03776630 | Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors(GYNO-MIR) | active not recruiting | N/A | 363 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07114653 | The Role of POLE Mutation in High Risk Endometrial Cancer. | recruiting | — | 150 | Far Eastern Memorial HospitalOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05862272 | A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis | recruiting | Phase 3 | 1,000 | Sumitomo Pharma Switzerland GmbHINDUSTRY | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07093593 | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs(RAMA) | not yet recruiting | N/A | 260 | Centre Georges Francois LeclercOTHER | 0 | Jul 30, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 11, 2025source: clinicaltrials